Search results
Author(s):
Ana Mola
,
Carmen Perez-Terzic
,
Randal Thomas
,
et al
Added:
3 years ago
The changing population landscape in the US has impacted the many levels of the US healthcare system. It is estimated that, by 2050, minority populations together will comprise approximately 50% of the total population.1 This demographic shift has prompted policy makers, scientists, researchers, educators, and healthcare providers to draft a series of national health initiatives to define,…
View more
Author(s):
Bernard R Chaitman
,
Harold H Schmitz
,
Carl L Keen
Added:
3 years ago
Dietary intake of a specific subclass of flavonoids known as flavanols has attracted increasing interest as a result of recent epidemiological, mechanistic, and human intervention studies suggesting potential beneficial cardiovascular effects. Among the wide variety of dietary flavanol sources, including apples, cranberries, purple grapes, red wine and teas, some cocoas and chocolates can be…
View more
Author(s):
Bernard R Chaitman
,
Harold H Schmitz
,
Carl L Keen
Added:
3 years ago
Dietary intake of a specific subclass of flavonoids known as flavanols has attracted increasing interest as a result of recent epidemiological,1,2 mechanistic,3,4,5 and human intervention studies suggesting potential beneficial cardiovascular effects.4,5,6 Among the wide variety of dietary flavanol sources, including apples, cranberries, purple grapes, red wine and teas, some cocoas and…
View more
Author(s):
Bernard R Chaitman
,
Harold H Schmitz
,
Carl L Keen
Added:
3 years ago
Dietary intake of a specific subclass of flavonoids known as flavanols has attracted increasing interest as a result of recent epidemiological mechanistic and human intervention studies suggesting potential beneficial cardiovascular effects. Among the wide variety of dietary flavanol sources, including apples, cranberries, purple grapes, red wine, and tea, some cocoas and chocolates can be…
View more
Author(s):
Lee Kaplan
,
Fatima Cody Stanford
,
Filip Knop
,
et al
Added:
8 months ago
Radcliffe Medical Education bring together a distinguished panel of globally renowned experts who provide guidance on navigating the ever-changing landscape of obesity and metabolic health management.
Under the chairmanship of Prof Jason Halford(University of Leeds, UK), the panel includingDr Lee Kaplan(Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital, US),Dr…
View more
Author(s):
Ramy Doss
,
Chiadi Ndumele
Added:
4 months ago
AHA 2023 — CardioNerds Ambassador, Dr Ramy Doss (Nazareth Hospital, US) is joined by Dr Chiadi E Ndumele (Johns Hopkins University, US) to talk about AHA's Presidential Advisory on Cardiovascular-Kidney-Metabolic Health (CKM).The presidential advisory focuses on the cardiovascular-kidney-metabolic (CKM) syndrome, a systemic disorder connecting heart disease, kidney disease, diabetes and obesity…
View more
Global Health, AI and Telemedicine with Dr Hunter Cherwek
Author(s):
Ankur Kalra
Added:
1 year ago
Podcast Episode
Author(s):
Francisco Lopez-Jimenez
Added:
3 years ago
For many years, scientists and clinicians have recognized the association between several relatively common conditions such as hypertension, abnormal glucose metabolism (diabetes and other milder forms of glucose intolerance), and obesity. The observed association has also included other factors such as abnormal lipids (cholesterol and triglycerides), elevated uric acid, and microscopic amounts…
View more
Author(s):
Billy A Caceres
,
Carl Streed
Added:
2 years ago
In this video Dr. Billy A. Caceres(Columbia University School of Nursing, US) meetsDr. Carl G. Streed (Boston University School of Medicine, Boston, MA, US) to give an introduction to the topic of cardiovascular health concerns among LGBTQ+ populations for healthcare professionals (including physicians, nurses, physician assistants) with expertise in primary care, cardiology, preventive…
View more
Author(s):
Javed Butler
Added:
2 years ago
In this short interview, Dr Javed Butler (University of Mississippi Medical Center, Jackson, MS, US) discusses the findings of an analysis from the EMPEROR Preserved trial. In EMPEROR-Preserved, empagliflozin treatment was associated with reduction in the risk of the primary endpoint of CV death or HF hospitalization in patients with HFpEF. In this analysis, presented at AHA 2021, the…
View more